Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.710
-0.270 (-9.06%)
At close: Dec 20, 2024, 4:00 PM
2.660
-0.050 (-1.85%)
After-hours: Dec 20, 2024, 4:30 PM EST
Daré Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -3.6 | -30.16 | -30.95 | -38.7 | -27.4 | -14.26 | |
| Depreciation & Amortization | 0.05 | 0.04 | 0.02 | 0.03 | 0.04 | 0.01 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | -0.2 | |
| Stock-Based Compensation | 2.33 | 2.53 | 2.16 | 1.6 | 0.74 | 0.46 | |
| Other Operating Activities | 0.35 | 0.08 | -0.02 | -0.42 | -0.16 | -0.03 | |
| Change in Accounts Receivable | 0.61 | 0.75 | -0.56 | -0.69 | 0.1 | -0.2 | |
| Change in Accounts Payable | -3.94 | 1.36 | -0.08 | 1.08 | -0.06 | 0.61 | |
| Change in Unearned Revenue | -6.12 | -4.57 | 7.76 | 8.98 | 0.54 | -0.24 | |
| Change in Other Net Operating Assets | 1.71 | -8.89 | 3.57 | -0.65 | 0.96 | 0.54 | |
| Operating Cash Flow | -8.01 | -38.86 | -18.09 | -28.76 | -25.23 | -13.32 | |
| Capital Expenditures | -0.62 | -0.63 | -0.06 | -0.01 | -0.02 | - | |
| Cash Acquisitions | - | - | - | - | - | 6.14 | |
| Investing Cash Flow | -0.62 | -0.63 | -0.06 | -0.01 | -0.02 | 6.14 | |
| Short-Term Debt Issued | - | - | - | - | 0.37 | - | |
| Long-Term Debt Issued | - | 0.6 | - | - | - | - | |
| Total Debt Issued | 0.56 | 0.6 | - | - | 0.37 | - | |
| Long-Term Debt Repaid | - | -0.33 | - | - | - | - | |
| Net Debt Issued (Repaid) | -0.03 | 0.27 | - | - | 0.37 | - | |
| Issuance of Common Stock | 1.18 | 10.65 | 1.34 | 75.85 | 24.76 | 5.15 | |
| Other Financing Activities | 4.72 | 4.72 | - | - | - | - | |
| Financing Cash Flow | 5.88 | 15.64 | 1.34 | 75.85 | 25.13 | 5.15 | |
| Foreign Exchange Rate Adjustments | 0.06 | -0.01 | -0.2 | -0.06 | 0.01 | -0.01 | |
| Net Cash Flow | -2.7 | -23.86 | -17 | 47 | -0.11 | -2.03 | |
| Free Cash Flow | -8.63 | -39.49 | -18.15 | -28.78 | -25.25 | -13.32 | |
| Free Cash Flow Margin | -458.66% | -1406.26% | -181.51% | - | - | - | |
| Free Cash Flow Per Share | -1.04 | -5.43 | -2.58 | -5.65 | -10.07 | -10.26 | |
| Levered Free Cash Flow | -21.31 | -27.18 | -6.8 | -15.28 | -15.27 | -5.61 | |
| Unlevered Free Cash Flow | -21.31 | -27.18 | -6.8 | -15.28 | -15.27 | -5.61 | |
| Change in Net Working Capital | 8.67 | 9.91 | -10.7 | -7.53 | -1.09 | -2.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.